trending Market Intelligence /marketintelligence/en/news-insights/trending/d363Pn38aXEIIIZ3NDQRaA2 content esgSubNav
In This List

Tonix Pharmaceuticals plans common stock offering

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Tonix Pharmaceuticals plans common stock offering

Tonix Pharmaceuticals Holding Corp. plans to offer and issue common stock in an underwritten public offering.

The company expects to use the net proceeds to support the continued development of TNX-102 SL for the treatment of post-traumatic stress disorder, including the HONOR study in military-related PTSD, to further develop other pipeline programs, for working capital and other general corporate purposes and possibly acquisitions of other companies, products or technologies.

Aegis Capital Corp. is acting as the sole book-running manager in the offering.